{"SPADE_UN_00652": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_00652", "Peptide Name": "A3-APO", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "RPDKPRPYLPRPRPPRPVR", "Sequence Length": 19, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial"], "Target Organism": "No MICs found in DRAMP database", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C106H176N38O23", "Mass": 2350.77, "PI": 12.0, "Net Charge": 6, "Hydrophobicity": -2.13, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Comments": "No comments found on DRAMP database", "Literature": [{"Title": "The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models.", "Pubmed ID": "20031377", "Reference": "Int J Antimicrob Agents. 2010 Apr;35(4)357-361.", "Author": "Szabo D, Ostorhazi E, Binas A, Rozgonyi F, Kocsis B, Cassone M, Wade JD, Nolte O, Otvos L Jr.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=20031377"}], "Frequent Amino Acids": "PRD", "Absent Amino Acids": "ACEFGHIMNOQSTUW", "Basic Residues": 7, "Acidic Residues": 1, "Hydrophobic Residues": 11, "Polar Residues": 9, "Positive Residues": 7, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_12439", "Similarity": 1.0, "Sequence": "RPDKPRPYLPRPRPPRPV"}, {"SPADE_ID": "SPADE_N_12441", "Similarity": 1.0, "Sequence": "RPDKPRPYLPRPRPPRPV"}, {"SPADE_ID": "SPADE_N_12442", "Similarity": 1.0, "Sequence": "RPDKPRPYLPRPRPPRPV"}]}}}